About CrossBridge Bio
CrossBridge Bio is a private company based in Houston, Texas, incorporated in 2023 in United States. It has reported $10,818,821 raised in one offering on Form D since November 2024. Its chief executive is Michael Torres.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 29, 2024 | Nov 4, 2024 | $10,818,821of $17.0M target | 23 | $470K | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on CrossBridge Bio's Form D filed Nov 4, 2024.
WM
William McKeon
Director
KT
Kyoji Tsuchikama
Executive officer, director and promoter
DI
Damir Illich
Director
PC
Patrick Crutcher
Director
MT
Michael Torres
Chief Executive Officer and director
ZA
Zhiqiang An
Promoter